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From the Editor
The Value of Value-based Purchasing
Many of our readers are no doubt aware of recent national newspaper headlines
trumpeting “Bribing Hospitals to do Better,”1 “Employers to Pay Bonuses to Good
Doctors,”2 and related stories. Astute readers of the medical literature have probably
seen terms like “Bridges to Excellence”3 and “Rewarding Results”4 representing a
clever blend of public and private efforts to extend the early gains of value-based
purchasing. Even foreign nations like the United Kingdom have transformed their
delivery system to reflect an unprecedented nationwide payment-for-performance
initiative.5 What exactly do these headlines, national programs and overseas
harbingers mean? Because value-based purchasing is such a broad, complex and
controversial topic, I will limit the discussion here to a brief review of the research
evidence, an update on recent progress, and a concentration on the future prospects
and challenges inherent in such a system.
First, some definitions – value-based purchasing, pay-for-performance or qualitybased purchasing are related concepts. It is clear that dramatic deficiencies in the
quality of care delivered in the United States have been widely documented.6
Indeed, aspects of this dilemma have been discussed in this space before.7 For our
purposes, value-based purchasing is defined as “payment or reputational strategies
aimed at providers that individual employers, employer coalitions or government
programs could plausibly adopt to stimulate the improvement of quality in
healthcare.”8 There appear to be different types of value-based purchasing extant in
the marketplace, including programs with funds going from the government to
hospitals, employers to health plans, and even health plans to hospitals and
individual physicians. We simply don’t have space to evaluate all aspects of this
fascinating recent development, but current evidence suggests that nearly a hundred
individual performance-based purchasing programs have been documented with
varying degrees of success and heterogeneous designs.9
The research evidence underlying value-based purchasing has recently been
thoroughly reviewed by the Agency for Healthcare Research and Quality (AHRQ) in
their report entitled, Strategies to Support Quality-based Purchasing: A Review of
the Evidence.8 In the executive summary accompanying this comprehensive AHRQ
report, the researchers note that because quality-based purchasing is in its infancy,
their first objective was to develop a conceptual model of how these strategies could
be used to create incentives for providers to improve care. The second objective was
to identify all the published, peer-reviewed, randomized, controlled trials of qualitybased purchasing and to summarize what was known about their relative
effectiveness. Finally, they sought to determine whether these outcome reports
convey meaningful information or are too influenced by chance events to be useful.
Indeed, a broad undertaking by whatever measure!
The AHRQ researchers concluded that there is some evidence that both payment and
reputational incentives can work but “to date there is little unequivocal data on which
to base quality-based purchasing strategy selection.”8 In other words, despite the
broad spectrum appeal and the logic behind paying more for better performers, the
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early returns are decidedly mixed. I believe Steinberg was right when he said, “The
challenge, therefore, is not to demonstrate that there already is a business case for
quality improvement in healthcare, rather it is to establish new incentives that will
create such a case.”10
What of recent progress around the nation given the somewhat shaky research
foundation just alluded to? Value-based purchasing has taken on an urgency in the
marketplace not seen previously, due in no small part to an acceleration in the
overall costs of healthcare, most especially the drug and hospital components. Again,
a detailed discussion of all of the various models would be burdensome. Let me
concentrate, then, on some recent research from our own Department of Health
Policy.
From a review that our team conducted of the published literature on value-based
purchasing, six key strategies used by the purchaser community emerged.11 By
focusing on the purchaser community, we can attempt to better understand the
concept of value-based purchasing. The six strategies include: 1) collecting
information and data on the quality of care provided by health plans and providers,
2) selective contracting with high quality plans or providers, 3) partnering with plans
or providers to improve quality, 4) promoting so-called Six Sigma quality in industrybased models for minimizing errors and waste, 5) educating consumers on the
many aspects of quality, and 6) rewarding or penalizing providers through a mixture
of financial incentives or disincentives. Our work (based on a nationwide survey of
purchasers in addition to the literature review) has contributed to the national
conversation about the appropriate mixture of tools and techniques to accomplish
value-based purchasing.
Given the somewhat flimsy research basis and our assessment of the market place,
what are some of the current and future challenges facing those involved in valuebased purchasing? Here is where the story gets very interesting! Among the many
challenges ahead for both purchasers and physicians include aspects of the following
six challenges. First, “efforts to motivate doctors will have minimal effect unless the
purchasers or insurers promoting incentive programs represent a substantial
proportion of a physician’s practice or unless different purchasers and insurers in
the same geographic area coordinate programs.”12 Simply put, we need to have
enough skin in the game to make it worth our while to effect dramatic structural
changes in what we do every day.
The second challenge is in the design and implementation of these programs and
getting the right mix of criteria for quality. We could quibble endlessly about which
measures are appropriate given the scores of research validated indicators now
readily available in the marketplace.
The third challenge involves the possibility that we may “unfairly penalize physicians
caring for patients who are at a socioeconomic disadvantage and may motivate the
physicians to reduce the number of patients for whom they provide care.” Epstein12
worries that rewards for quality could therefore help make the rich richer and the
poor poorer.
The fourth challenge involves the different mindset by what we mean when we say
“a healthy purchaser.” Generally, a healthy company relates to a healthy financial
position or so-called bottom line. Some of our leading researchers believe that a
healthy company of the future may take on a different context relating more to
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measurable health indices of the employers.13 Perhaps, a new partnership-based
healthcare strategy is necessary for employers integrating health into the very
culture of the business and encouraging and enabling thoughtful use of resources for
the future.
The fifth challenge is the perceived risk that we may be creating a two-class
healthcare system. Physicians achieving the highest scores could become an elite
class that charges more for their services. This may drive up overall costs and limit
access for patients unable to pay the price. Also, in this two-class health system, is
the concern about what society ought to do with those physicians or provider groups
with consistently lower quality scores. Should we mandate remedial continuing
medical education, changes in recertification or the actual credentialing process at
hospitals and other systems?
The sixth challenge is one of the cost and reliability of the quality measurement
process itself. Without a widespread adoption of computerized medical records and
their linkage back to legacy systems, we may not be able to effect broad-based
adoption of value-based purchasing. For example, using an estimate of $30
to $50 to abstract a chart by hand and an average of 50 charts per physician, annual
data collection costs in the absence of an electronic medical record could easily
amount to $2,500 per physician. In a metropolitan area like Philadelphia, total
collection costs for the data alone could run easily to the millions of dollars.
Given the aforementioned six challenges, is all lost then and should we abandon
value-based purchasing pilot projects across the country? Certainly not! In my view,
value-based purchasing represents a watershed in the quality measurement and
improvement movement in our nation. I am confident of our ability to create
research proven valid and reliable measures that will help us guide reimbursement
decision making. Physician leadership in this process will be crucial to help us avoid
some of the treacherous currents flowing around the aforementioned challenges.
In that spirit, I am very proud of Jefferson Medical College and, particularly, the
Department of Health Policy. Our early work with the Commonwealth Fund in New
York City and our Issue Brief, How Does Quality Enter into Healthcare Purchasing
Decisions,11 has been cited as one of the most important healthcare projects
emanating from the Commonwealth Fund in the last two years. In addition, with our
colleagues at the National Business Coalition on Health in Washington, D.C., and the
Healthcare 21 Business Coalition in Knoxville, Tennessee, we have launched a
nationwide program entitled, “The College for Advanced Management of Health
Benefits.” The college was created to help employee benefit managers meet
the growing challenges of providing high quality health benefits and managing rising
benefit costs. According to our marketing brochure,14 the college offers “a practical
intensive program that focuses on benefits purchasing techniques and skills that
emphasize improving the value, quality cost ratio, and effectiveness of healthcare
services purchased on behalf of employees.” In a nutshell, we are bringing to bear
our research knowledge into a focused hands-on training program for the actual
purchasers of medical care.
We have a new book in the works to be published later this year entitled, Closing the
Quality Chasm, published by Jones and Bartlett. This book will summarize many
aspects of our work on value-based purchasing and provide the reader with one-stop
shopping about these and related quality of care issues. Finally, the focus of our 11th
Annual Summer Seminar on July 15, 2005, will be on value-based purchasing.
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No doubt, there are many skeptics among our readers regarding the value of valuebased purchasing. After all, the research evidence is muddied and physician
autonomy, once again, appears to be on the chopping block. I, for one, am confident
that our own work coupled with many of our colleagues around the nation and
those directly involved in programmatic development will convincingly demonstrate
to the skeptics that getting paid more for doing a better job is an exciting and fruitful
public policy we can all collective embrace. As usual, I am interested in your views
and you can reach me at my e-mail address david.nash@jefferson.edu.
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